Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RHOA |
| Upstream (Parents) |
|---|
| (<<) ANXA2 → RHOA |
| (<<) GOT1 → RHOA |
| (<<) GSTZ1 → RHOA |
| (<<) MAFF → RHOA |
| (<<) PCK2 → RHOA |
| (<<) RBKS → RHOA |
| (<<) S100P → RHOA |
| (<<) SMURF2 → RHOA |
| (<<) SOD1 → RHOA |
| (<<) TMSB10 → RHOA |
| Downstream (Children) |
|---|
| RHOA → ACTB (>>) |
| RHOA → ADAM17 (>>) |
| RHOA → ARHGEF2 (>>) |
| RHOA → CREB3L1 (>>) |
| RHOA → CTNNB1 (>>) |
| RHOA → EPHA4 (>>) |
| RHOA → HBEGF (>>) |
| RHOA → IGFBP2 (>>) |
| RHOA → KCNN4 (>>) |
| RHOA → MAT2A (>>) |
| RHOA → NBL1 (>>) |
| RHOA → NEDD4 (>>) |
| RHOA → PIP5K1C (>>) |
| RHOA → PLAU (>>) |
| RHOA → PRKCD (>>) |
| RHOA → RASSF1 (>>) |
| RHOA → STX1A (>>) |
| RHOA → TAGLN2 (>>) |
| RHOA → TPM1 (>>) |
| RHOA → TPM4 (>>) |
| RHOA → TTC9 (>>) |
| RHOA → YWHAH (>>) |
| RHOA → YWHAQ (>>) |
